Dominik Stämpfli

Dr. Dominik Stämpfli is a Lecturer at the Department of Chemistry and Applied Biosciences at ETH Zürich, with a combined appointment as a clinical pharmacist at Kantonsspital Baden. His research focuses on Clinical Pharmacy and Pharmacoepidemiology, emphasizing drug-related problem prevention, opioid deprescribing strategies, and public health interventions. He holds roles in Swiss pharmacy education, including membership in the Commission for the Federal Examinations in Pharmacy and the Study Programme Commission CAS Community Pharmacy.

Education includes a pharmacy degree from the University of Basel (2008–2013) and a doctorate in pharmaceutical care (2014–2018). His postdoctoral work at Basel expanded into clinical pharmacy roles, including managing transferable skills programs (2018–2019). His research spans pharmacovigilance, medication safety, and interprofessional collaboration in healthcare.

Key research themes include:

• Optimizing opioid deprescribing protocols to reduce rehospitalization risks
• Developing tools like the PAR-Risk Score for hospital readmission prediction
• Pharmacy-led interventions for hepatitis C screening and influenza vaccination
• Evaluating medication discrepancies and their clinical/economic impacts

He is actively involved in:

• Teaching Therapeutic Skills, Clinical Trainings, and Interprofessional Patient Pathways at ETH
• Professional organizations such as the Pharmaceutical Care Network Europe and Swiss Academy of Pharmaceutical Sciences

His work bridges academic research and clinical practice, with a focus on improving patient safety through pharmacist-led initiatives.